The decisions that determine Phase 2 timing are made, or missed, in the first two quarters after the IND opens.
White Paper
IND Ready Is Not Phase 2 Ready
Related Resources
All Resources
post
Biologics vs Small Molecules: A New Era in Drug Development
Read More
case-study
Syner-G Partners with Leading Supplier in Life Sciences to Build Out New cGMP Compliant Facilities
Read More
case-study
Mobilizing Pharmaceutical Technology Transfers to a Contract Development and Manufacturing Organization (CDMO)
Read More
post
CFD Applications in Design of Manufacturing Processes and Facilities
Read More
Let's move from science to success.
Let’s Talk